NASDAQ Companies

ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and […]

CARLSBAD, Calif., March 07, 2025 (GLOBE NEWSWIRE) — AppTech Payments Corp. (“AppTech or the “Company”) (NASDAQ: APCX), a fintech company, […]

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) — Brag House Holdings, Inc. (“Brag House” or the “Company”), a premier media […]

KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and […]

ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) — Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company […]

– Granted Listing Extension from Nasdaq Hearing Panel – QUINCY, Mass., March 07, 2025 (GLOBE NEWSWIRE) — Stran & Company, […]

EAGLE, Idaho, March 07, 2025 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]

SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company […]

SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to […]

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using […]